Diabetes mellitus is a group of diseases that causes a person to have high levels of sugar (glucose) in the blood or, hyperglycemia. The two most common forms of diabetes are type 1 and type 2.
Patients with type 1 diabetes do not produce insulin. Type 1 diabetes mellitus is a life-long disease that requires daily insulin injections and can lead to other serious medical complications.
The incidence, of the chronic and devastating disease of type 1 diabetes, has been rising at a rapid rate.1
Approximately 10% of diabetes cases are type 1.
Patients with type 1 diabetes do not produce insulin but the cause is unknown. Normally the immune system produces antibodies which protect the body from foreign invaders such as; viruses, bacteria and germs. In patients with type 1 diabetes, the immune system mistakenly attacks and destroys the healthy insulin-producing beta cells in the pancreas.
The result is little or no insulin to transport the sugar into cells. Sugar builds up in the blood stream causing systemic damage.
The symptoms of type 1 diabetes can present suddenly and at any age, but most patients with type 1 diabetes are diagnosed in early childhood or adolescence. Symptoms might include; excessive urination, thirst, constant hunger, unexplained weight loss, changes in vision, and fatigue.
Serious complications caused by type 1 diabetes2-4:
Researchers have shown mesenchymal stem cells have the potential to treat many chronic diseases, including type 1 diabetes. Mesenchymal stem cells have the ability to:
In type 1 diabetes, mesenchymal stem cells can help stop beta cell destruction and preserve beta cell function and mass.1,5
Mesenchymal stem cells can modulate a patient’s immune system so that it no longer mistakenly attacks the beta cells and can also repair damaged beta cells. The patient’s new beta cells will function appropriately, correctly control blood sugar levels.
Preliminary results from one clinical trial showed the effect on the immune system by mesenchymal stem cells allowed beta cells to regenerate and improve glycemic control in patients with long-standing type 1 diabetes.6 After treatment, a patient will notice continuous improvement over time.
For optimal results. the Stem Cells Transplant Institute recommends the use of human umbilical cord mesenchymal stem cells (hUC-MSCs) for the treatment of type 1 diabetes. Treatment includes:
Using stem cells to control the patient’s immune system is challenging. In some trials when beta cells were created or transplanted into a patient, their immune system would continue to target and destroy the new cells.
Scientists are researching ways to better protect the new beta cells from future destruction.
We use only umbilical cord stem cells that are derived exclusively from umbilical cord donations.
The umbilical cord stem cells from are collected after informed consent has been given by the parent, or parents, and only after the delivery of the baby.
The collection follows strict ethical protocols ensuring the stem cells are from safe, reliable sources using a non-invasive, simple and painless procedure. Once collected, the cord blood is then screened for
The stem cells are administered intravenously.
Costa Rica has one of the best healthcare systems in world and is ranked among the highest for medical tourism. Using the most advanced technologies, the team of experts at The Stem Cells Transplant Institute believes in the potential of stem cell therapy for the treatment of diabetes. We are committed to providing personalized service and the highest quality of care to every patient.